Expression of insulin-like growth-factor-1 receptor (IGF-1R) in peripheral nerve sheath tumors in neurofibromatosis type 1

Anticancer Research

Volumn 27, Issue 4 A, 2007, Pages 2085-2090

  Friedrich, R E ^a,b   Keiner, D ^a   Hagel, C ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^b UNIVERSITY OF HAMBURG   (Germany)

Author keywords

IGF 1R; Insulin like growth factor 1 receptor; MPNST; Neurofibroma; Neurofibromatosis; Peripheral nerve sheath tumor

Indexed keywords

CD34 ANTIGEN; EPITHELIAL MEMBRANE ANTIGEN; KI 67 ANTIGEN; PROTEIN S 100; SOMATOMEDIN C RECEPTOR;

CELL CULTURE; CELL MATURATION; CELL PROLIFERATION; CONFERENCE PAPER; CONTROLLED STUDY; FIBROBLAST; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; NEUROFIBROMATOSIS; PERIPHERAL NERVE TUMOR; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; SCHWANN CELL; TUMOR GROWTH;

ANTIGENS, CD34; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KI-67 ANTIGEN; MALE; NERVE SHEATH NEOPLASMS; NEUROFIBROMATOSIS 1; RECEPTOR, IGF TYPE 1; S100 PROTEINS; SCHWANN CELLS;

EID: 34250759198     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (28)

1. Lammert M, Friedman JM, Kluwe L and Mautner VF: Prevalence of neurofibromatosis 1 in German children at elementary school enrollment. Arch Dermatol 141: 71-74, 2005.
2. Cheng HL, Randolph A, Yee D, Delafontaine P, Tennekoon G and Feldman EL: Characterization of insulin-like growth factor-I and its receptor and binding proteins in transected nerves and cultured Schwann cells. J Neurochem 66: 525-536, 1996.
3. Jessen KR and Mirsky R: Why do Schwann cells survive in the absence of axons? Ann NY Acad Sci 883: 109-115, 1999.
4. Schumacher M, Jung-Testas I, Robel P and Baulieu EE: Insulin-like growth factor I: a mitogen for rat Schwann cells in the presence of elevated levels of cyclic AMP. Glia 8: 232-240, 1993.
5. Syroid DE, Zorick TS, Arbet-Engels C, Kilpatrick TJ, Eckhart W and Lemke G: A role for insulin-like growth factor-I in the regulation of Schwann cell survival. J Neurosci 19: 2059-2068, 1999.
6. Baserga R, Peruzzi F and Reiss K: The IGF-1 receptor in cancer biology. Int J Cancer 107: 873-877, 2003.
7. Gutmann DH, Aylsworth A, Carey JC, Korf B, Marks J, Pyeritz RE, Rubenstein A and Viskochil D: The diagnostic evaluation and multidisciplinary management of neurofibromatosis 1 and neurofibromatosis 2. JAMA 278: 51-57, 1997.
8. Ariza A, Bilbao JM and Rosai J: Immunohistochemical detection of epithelial membrane antigen in normal perineurial cells and perineurioma. Am J Surg Pathol 12: 678-683, 1988.
9. Khalifa MA, Montgomery EA, Ismiil N andAzumi N: What are the CD34+ cells in benign peripheral nerve sheath tumors? Double immunostaining study of CD34 and S-100 protein. Am J Clin Pathol 114: 123-126, 2000.
10. Takeuchi A and Ushigome S: Diverse differentiation in malignant peripheral nerve sheath tumours associated with neurofibromatosis-1: an immunohistochemical and ultrastructural study. Histopathology 39: 298-309, 2001.
11. Theaker JM, Gatter KC and Puddle J: Epithelial membrane antigen expression by the perineurium of peripheral nerve and in peripheral nerve tumours. Histopathology 13: 171-179, 1988.
12. Weiss SW and Nickoloff BJ: CD-34 is expressed by a distinctive cell population in peripheral nerve, nerve sheath tumors, and related lesions. Am J Surg Pathol 17: 1039-1045, 1993.
13. Friedrich RE, Hagel C, Brehme Z, Kluwe L and Mautner VF: Ki-67 proliferation-index (MIB-1) of neurofibromas in neurofibromatosis type 1 patients. Anticancer Res 23: 953-955, 2003.
14. Badache A and De Vries GH: Neurofibrosarcoma-derived Schwann cells overexpress platelet-derived growth factor (PDGF) receptors and are induced to proliferate by PDGF BB. J Cell Physiol 177: 334-342, 1998.
15. Badache A, Muja N and De Vries GH: Expression of Kit in neurofibromin-deficient human Schwann cells: role in Schwann cell hyperplasia associated with type 1 neurofibromatosis. Oncogene 17: 795-800, 1998.
16. Cunha KS, Barboza EP and Da Fonseca EC: Identification of growth hormone receptor in localised neurofibromas of patients with neurofibromatosis type 1. J Clin Pathol 56: 758-763, 2003.
17. Huang SS and Huang JS: TGF-beta control of cell proliferation. J Cell Biochem 96: 447-462, 2005.
18. Kadono T, Soma Y, Takehara K, Nakagawa H, Ishibashi Y and Kikuchi K: The growth regulation of neurofibroma cells in neurofibromatosis type-1: increased responses to PDGF-BB and TGF-beta 1. Biochem Biophys Res Commun 198: 827-834, 1994.
19. Kadono T, Kikuchi K, Nakagawa H and Tamaki K: Expressions of various growth factors and their receptors in tissues from neurofibroma. Dermatology 201: 10-14, 2000.
20. Ling BC, Wu J, Miller SJ, Monk KR, Shamekh R, Rizvi TA, Decourten-Myers G, Vogel KS, DeClue JE and Ratner N: Role for the epidermal growth factor receptor in neurofibromatosis-related peripheral nerve tumorigenesis. Cancer Cell 7: 65-75, 2005.
21. Parkinson DB, Bhaskaran A, Droggiti A, Dickinson S, D'Antonio M, Mirsky R and Jessen KR: Krox-20 inhibits Jun-NH2-terminal kinase/c-Jun to control Schwann cell proliferation and death. J Cell Biol 164: 385-394, 2004.
22. Parkinson DB, Dong Z, Bunting H, Whitfield J, Meier C, Marie H, Mirsky R and Jessen KR: Transforming growth factor beta (TGF β) mediates Schwann cell death in vitro and in vivo: examination of c-Jun activation, interactions with survival signals, and the relationship of TGF β-mediated death to Schwann cell differentiation. J Neurosci 21: 8572-8585, 2001.
23. Perosio PM and Brooks JJ: Expression of nerve growth factor receptor in paraffin-embedded soft tissue tumors. Am J Pathol 132: 152-160, 1988.
24. Ridley AJ Ridley AJ, Davis JB, Stroobant P and Land H: Transforming growth factors-beta 1 and beta 2 are mitogens for rat Schwann cells. J Cell Biol 109: 3419-3424, 1989.
25. Holtkamp N, Mautner VF, Friedrich RE, Harder A, Hartmann C, Theallier-Janko A, Hoffmann KT and von Deimling A: Differentially expressed genes in neurofibromatosis 1-associated neurofibromas and malignant peripheral nerve sheath tumors. Acta Neuropathol (Berl) 107: 159-168, 2004.
26. Watanabe T, Oda Y, Tamiya S, Masuda K and Tsuneyoshi M: Malignant peripheral nerve sheath tumour arising within neurofibroma. An immunohistochemical analysis in the comparison between benign and malignant components. J Clin Pathol 54: 631-636, 2001.
27. Yasuda T, Sobue G, Mitsuma T, Takahashi A and Hashizume Y: Nerve growth factor receptor immunoreactivity in human benign peripheral nerve sheath tumor. Acta Neuropathol (Berl) 77: 591-598, 1989.
28. Larsson O, Girnita A and Girnita L: Role of insulin-like growth factor 1 in receptor signalling in cancer. Br J Cancer 92: 2097-2101, 2005.